| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |